NuVasive (NSDQ:NUVA) this week announced that it appointed Matthew Harbaugh as executive VP and chief financial officer, effective immediately.

Harbaugh replaces Rajesh Asarpota, who is transitioning from the company. He has more than 25 years of experience in finance, business and strategy and operations management. Harbaugh will be responsible for overseeing all financial aspects of the company and will report directly to CEO Christopher Barry.

“With his financial, operational and leadership experience at large, global companies, Matt is an excellent fit for NuVasive as we enter our next stage of growth,” Barry said in a news release. “We are confident that his skills and expertise will help us continue building and transforming the organization and execute our five-year strategic plan.”

Prior to going NuVasive, Harbaugh served as the president of the specialty generics business at Mallinckrodt and served as CFO for more than five years. He has also held a number of financial management positions at Covidien Pharmaceuticals and Monsanto Company.

Asarpota will remain with the company as an advisor until May to assist Harbaugh in the transition of duties. He will provide consulting services until September this year.